VYNE Therapeutics Inc.

Q1 2026 13F Holders

Symbol
VYNE
CUSIP
92941V308
Type
Equity
Class
COM
Num filers
45
Total reported value, excl. options
$8.46M
Manager Report Date Value ($000) Shares Option Type